FOR IMMEDIATE RELEASE
Nextgen Molecular Supplies Announces SAHPRA Approval of Non-Invasive
Colorectal Cancer Screening Test
24 th October 202- Nextgen Molecular Supplies, a leader in supply of innovative healthcare solutions, is thrilled to announce that the South African Health Products Regulatory Authority (SAHPRA) has granted approval for its groundbreaking non- invasive colorectal cancer screening test. This milestone represents a significant advancement in the early detection and prevention of colorectal cancer, one of the leading causes of cancer-related deaths in South Africa. Colorectal cancer often develops without noticeable symptoms, making regular screening essential for early detection. The newly approved test offers a non-invasive, user-friendly alternative to traditional screening methods, utilizing advanced technology to detect biomarkers associated with colorectal cancer through a simple stool sample. This approach not only enhances patient comfort but also encourages more individuals to participate in regular screenings.
Key Benefits of the Non-Invasive Screening Test:
- User-Friendly: The sample can be collected in the privacy of one’s home, making it more accessible for patients.
- Early Detection: By identifying potential issues earlier, the test can significantly improve treatment outcomes and survival rates.
- Cost-Effective: This screening option reduces the need for more invasive procedures, saving healthcare costs for both patients and providers.
“We are proud to receive SAHPRA’s approval for our non-invasive colorectal cancer screening test, which underscores our commitment to improving patient outcomes through innovative healthcare solutions tailored for Africa,” said Dr Gerald Kimbi-Chiafiinii, Managing Director of Nextgen Molecular Supplies. “Our aim is to empower individuals to take charge of their health by making colorectal cancer screening more accessible and less daunting.”
Nextgen Molecular Supplies will begin rolling out the test to healthcare providers and facilities across South Africa in the coming months, ensuring that this vital screening option is readily available to those who need it.
For more information about the non-invasive colorectal cancer screening test or to schedule an interview with Dr Kimbi-Chiafiinii, please contact:
Elma Deysel
Nextgen Molecular Supplies
+27 871489309
customer_care@ngms.co.za
www.ngms.co.za
About Nextgen Molecular Supplies
NextGen Molecular Supplies Mission is to provide useful, high-quality products and
services that advance scientific discovery and improve healthcare. Life Science
Research and Clinical Diagnostics. Our research product line includes the most
advance and effective solutions for Molecular biology. Our diagnostic division is
focused on providing quicker (Point of Care)/ Near Patient Diagnostic solutions at an
affordable price. These will help to limit the effect of poor laboratory infrastructure
within the continent. Our test has the potential to drastically reduce the waiting period
for determine laboratory results as well as time spent by the patient in the hospital.